Momeson Inhalation Capsule 220 mcg

Momeson Inhalation Capsule 220 mcg Uses, Dosage, Side Effects, Food Interaction and all others data.

Trade Name Momeson Inhalation Capsule 220 mcg
Generic Mometasone Furoate (Inhalation Capsule)
Weight 220 mcg
Type Inhalation Capsule
Therapeutic Class Corticosteroid, Respiratory corticosteroids
Manufacturer Incepta Pharmaceuticals Ltd.
Available Country Bangladesh
Last Updated: October 19, 2023 at 6:27 am
Momeson Inhalation Capsule 220 mcg
Momeson Inhalation Capsule 220 mcg

Uses

Mometasone Furoate is indicated for the maintenance treatment of asthma as prophylactic therapy in patients 4 years of age and older. It is not indicated for the relief of acute bronchospasm. It is not indicated in children less than 4 years of age.

Dosage

Momeson Inhalation Capsule 220 mcg dosage

Recommended Dosages in Patients 4 Years of Age and Older.Previous Therapy: Patients ≥ 12 years who received bronchodilators alone Recommended Starting Dose:220 µg once daily in the evening Highest Recommended Daily:220 µg twice daily or as 440 µg once daily Previous Therapy: Patients ≥ 12 years who received inhaled corticosteroids Recommended Starting Dose:220 µg once daily Highest Recommended Daily:440 µg once daily or 440 µg twice daily. Previous Therapy: Patients ≥ 12 years who received oral corticosteroids Recommended Starting Dose:4400 µg once daily Highest Recommended Daily:440 µg once daily or 440 µg twice daily.

Side Effects

Generally side effects are mild like headache, viral infection, sore throat, nosebleeds and coughing. Systemic and local corticosteroid use may result few side effects like candida infection, immunosuppression, hypercorticism, adrenal suppression, growth effects, glaucoma and cataracts.

Precaution

Use with caution in active or inactive tuberculosis infection, herpes simplex virus infection of the eye, untreated infections affecting the body as a whole etc.

Interaction

Ketoconazole, a strong inhibitor of cytochrome P4503A4 may increase plasma levels of Mometasone Furoate during concomitant dosing.

Pregnancy & Breastfeeding use

Pregnancy: There are no adequate and well-controlled studies in pregnant women. Mometasone Furoate, like other corticosteroids should be used during pregnancy only if the potential benefits justify the potential risk to the fetus.Lactation: It is not known if Mometasone Furoate is excreted in human milk. Since other corticosteroids are excreted in human milk, caution should be used when Mometasone Furoate is administered to nursing women.

Contraindication

Hypersensitivity to any of the ingredients of this preparation contraindicates its use. Mometasone Furoate therapy is contraindicated in the primary treatment of status asthmaticus or other acute episodes of asthma where intensive measures are required.

Acute Overdose

There are no data available on the effects of acute or chronic over dosage with Mometasone Furoate. Because of low systemic bioavailability and an absence of acute drug-related systemic findings in clinical studies, overdose is unlikely to require any therapy other than observation.

Storage Condition

Protect from light, store in cool & dry place. Do not store above 30° C. Keep out of the reach of children. Protect from freezing. Insert the Inhalation Capsule or ConviCap in the ConviHaler just prior to use to protect from deterioration by moisture

Innovators Monograph

You find simplified version here Momeson Inhalation Capsule 220 mcg


*** Taking medicines without doctor's advice can cause long-term problems.
Share